Continuous Glucose Monitoring for Outpatient Diabetes Management After Hospital Discharge
This study aims to improve patient awareness of the utility of continuous glucose monitoring systems in blood glucose monitoring and to improve patient satisfaction regarding diabetes care, particularly in the matter of blood glucose monitoring, at the transitions of care from the inpatient setting to the ambulatory setting.
Conditions studied
Type 2 Diabetes Mellitus (T2DM), Type 1 Diabetes Mellitus (T1DM), Hyperglycemia
About this study
This study aims to improve patient awareness of the utility of continuous glucose monitoring systems in blood glucose monitoring and to improve patient satisfaction regarding diabetes care, particularly in the matter of blood glucose monitoring, at the transitions of care from the inpatient setting to the ambulatory setting.
Interventions
- Device: Libre 3 Plus Continuous Glucose Monitor — Subjects in this arm will start using the Libre 3 Plus continuous glucose monitor.
- Device: Dexcom G7 Continuous Glucose Monitor — Subjects in this arm will start using the Dexcom G7 continuous glucose monitor.
Primary outcomes
- Questionnaire responses regarding patient satisfaction and opinion regarding use of continuous glucose monitoring system (From enrollment until follow-up telephone visit 2-3 weeks after discharge)
- Questionnaire responses regarding patient satisfaction and opinion regarding quality of diabetes care (From enrollment until follow-up telephone visit 2-3 weeks after discharge)
- Questionnaire responses regarding patient familiarity with continuous glucose monitoring (From enrollment until follow-up telephone visit 2-3 weeks after discharge)
Eligibility information
Study locations
- Vanderbilt University Medical Center, Nashville, Tennessee 37232 United States
Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.